This systematic review and meta-analysis is the first to evaluate the evidence for an
association between metformin use and cancer outcomes in patients undergoing treatment …

Overweight and obesity have reached pandemic levels on a worldwide basis and are
associated with increased risk and worse prognosis for many but not all malignancies …

Several epidemiological studies have identified diabetes as a risk factor for colorectal
cancer (CRC). The potential pathophysiological mechanisms of this association include …

Introduction Though a meta-analysis reported the effect of diabetes on colorectal prognosis
in 2013, a series of large-scale long-term cohort studies has comprehensively reported the …

Diabetes mellitus (DM) and hyperglycemia have been shown to have significant effects on
the incidence, chemoresistance, and prognosis of colorectal cancer (CRC), as well as the …

Studies have reported conflicting results on the association between body mass index (BMI)
and prognosis of colorectal cancer. Therefore, we have conducted a meta-analysis of …

Physical activity is emerging from epidemiologic research as a lifestyle factor that may
improve survival from colorectal, breast, and prostate cancers. However, there is …

In recent years, because of improved cancer screening, detection and treatment modalities,
a rapid increase in the population of colorectal and other cancer survivors has been …

The disorders of gastrointestinal (GI) tract including intestine and colon are common in the
patients with diabetes mellitus (DM). DM induced intestinal and colonic structural and …

Objective To assess the association between diabetes mellitus (DM) and metformin use with
prognosis and outcomes of non‐muscle‐invasive bladder cancer (NMIBC) Patients and …